---
figid: PMC5000709__ijms-17-01312-g001
figtitle: Kallistatin inhibits oxidative stress, inflammation and apoptosis through
  inhibiting TNFA signaling and promotes NO production through eNOS stimulation
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bos taurus
- Gallus gallus
- Lareunionomyces loeiensis
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC5000709
filename: ijms-17-01312-g001.jpg
figlink: /pmc/articles/PMC5000709/figure/ijms-17-01312-f001/
number: F1
caption: 'Kallistatin inhibits oxidative stress, inflammation and apoptosis through
  inhibiting TNF-α signaling and promotes NO production through eNOS stimulation.
  Kallistatin blocks TNF-α signaling through competitive binding to TNFR. This inhibits
  downstream signaling pathways that are activated by TNF-α, such as IκB/NF-κB and
  p38 MAPK pathway, which activate many pro-inflammatory and pro-angiogenic markers,
  such as TNF-α, VEGF, interleukins, MCP-1, MMPs and adhesion molecules. Kallistatin
  also inhibits TNF-α induces oxidative stress and the caspase cascade to induce apoptosis
  through TNFR-1. Alternatively, kallistatin is able to directly inhibit NADPH oxidase
  activity to attenuate ROS production, as well as activating eNOS through KLF4 to
  produce NO, which neutralizes ROS []. Abbreviations: endo-PC-endothelial progenitor
  cell, HUVEC-human umbilical vein endothelial cell, TNF-α-tumor necrosis factor alpha.
  Abbreviations: Akt/PKB—protein kinase B; ATF1—activating transcription factor 1;
  Bim—Bcl2 binding protein; eNOS—endothelial nitric oxide synthase; IκB—inhibitor
  of nuclear factor κ B; IKK—IκB kinase; JNK—c-Jun N-terminal kinase; KLF4—kruppel
  like factor 4; MAPK—mitogen activated protein kinase; MKK—MAPK kinase; NADPH—nicotinamide
  adenine dinucleotide phosphate; NF-κB—nuclear factor κB; NO—nitric oxide; P—phosphorylation;
  PI3K—phosphoinositide 3 kinase; ROS—reactive oxygen species; TNF-α—tumor necrosis
  factor alpha; TNFR—TNF-α receptor. The blue arrow lines indicate promotional activity;
  the red stop lines indicate inhibiting activity; the red dashed cross indicates
  degradation.'
papertitle: The Potential Role of Kallistatin in the Development of Abdominal Aortic
  Aneurysm.
reftext: Jiaze Li, et al. Int J Mol Sci. 2016 Aug;17(8):1312.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.951723
figid_alias: PMC5000709__F1
figtype: Figure
redirect_from: /figures/PMC5000709__F1
ndex: 3eb06213-def2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5000709__ijms-17-01312-g001.html
  '@type': Dataset
  description: 'Kallistatin inhibits oxidative stress, inflammation and apoptosis
    through inhibiting TNF-α signaling and promotes NO production through eNOS stimulation.
    Kallistatin blocks TNF-α signaling through competitive binding to TNFR. This inhibits
    downstream signaling pathways that are activated by TNF-α, such as IκB/NF-κB and
    p38 MAPK pathway, which activate many pro-inflammatory and pro-angiogenic markers,
    such as TNF-α, VEGF, interleukins, MCP-1, MMPs and adhesion molecules. Kallistatin
    also inhibits TNF-α induces oxidative stress and the caspase cascade to induce
    apoptosis through TNFR-1. Alternatively, kallistatin is able to directly inhibit
    NADPH oxidase activity to attenuate ROS production, as well as activating eNOS
    through KLF4 to produce NO, which neutralizes ROS []. Abbreviations: endo-PC-endothelial
    progenitor cell, HUVEC-human umbilical vein endothelial cell, TNF-α-tumor necrosis
    factor alpha. Abbreviations: Akt/PKB—protein kinase B; ATF1—activating transcription
    factor 1; Bim—Bcl2 binding protein; eNOS—endothelial nitric oxide synthase; IκB—inhibitor
    of nuclear factor κ B; IKK—IκB kinase; JNK—c-Jun N-terminal kinase; KLF4—kruppel
    like factor 4; MAPK—mitogen activated protein kinase; MKK—MAPK kinase; NADPH—nicotinamide
    adenine dinucleotide phosphate; NF-κB—nuclear factor κB; NO—nitric oxide; P—phosphorylation;
    PI3K—phosphoinositide 3 kinase; ROS—reactive oxygen species; TNF-α—tumor necrosis
    factor alpha; TNFR—TNF-α receptor. The blue arrow lines indicate promotional activity;
    the red stop lines indicate inhibiting activity; the red dashed cross indicates
    degradation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SERPINA4
  - NCF1
  - ING1
  - PLEK
  - CLEC11A
  - AKAP13
  - NSFL1C
  - H3P37
  - CD33
  - STXBP1
  - NCF2
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KLF4
  - AKT1
  - PTK2B
  - AKT2
  - AKT3
  - NFKB1
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK3
  - MAPK8
  - MAPK9
  - MAPK10
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - NOS3
  - ENO4
  - BCL2L11
  - ATF1
  - GDNF
  - TNFRSF1A
  - TNF
  - DECR1
  - Ncf1
  - Mfge8
  - Ruvbl2
  - Nsfl1c
  - Metap2
  - Ncf2
  - Pik3r1
  - Klf4
  - Akt1
  - Akt2
  - Nfkb1
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Nos3
  - Mapk8
  - Bcl2l11
  - Atf1
  - Tnfrsf1a
  - Tnf
  - Decr1
  - Cyba
  - Ddx39b
  - Pik3cg
  - METAP2
  - Phox
  - PPO1
  - p47
  - prtp
  - CG42383
  - und
  - tral
  - glo
  - IKKepsilon
  - key
  - IKKbeta
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Dif
  - dl
  - Rel
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - p38a
  - Hrb87F
  - p38c
  - MKP-4
  - rl
  - bsk
  - babo
  - wgn
  - egr
  - klf4
  - klf17
  - mapk14a
  - mapk8b
  - bcl2l11
  - atf1
  - tnfb
---
